Validation of the Achalasia Patient-Reported Outcomes Questionnaire.
John E PandolfinoDustin A CarlsonJosie McGarvaPeter J KahrilasMichael VaeziDavid A KatzkaTiffany H TaftPublished in: Alimentary pharmacology & therapeutics (2022)
The APRO is a reliable and valid measure of achalasia symptoms that addresses the limitations of existing questionnaires. Symptom anxiety and hypervigilance moderate the relationship between APRO and quality of life; 33% of patients with achalasia exhibit concerning patterns in symptom severity, anxiety and hypervigilance that may contribute to poorer outcomes.